Intercept Pharmaceuticals Inc
F:I4P

Watchlist Manager

Intercept Pharmaceuticals Inc

F:I4P

Watchlist

Price: 17.52 EUR

Market Cap: 732.8m EUR

Have any thoughts about
Intercept Pharmaceuticals Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 17.52 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

I4P Alert

Intercept Pharmaceuticals Inc

17.52

0.00 (0%)

52 Week Range	9.782 17.775
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Intercept Pharmaceuticals Inc

What unique competitive advantages
does Intercept Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Intercept Pharmaceuticals Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Intercept Pharmaceuticals Inc.

What unique competitive advantages
does Intercept Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Intercept Pharmaceuticals Inc face in the near future?

Summarize the latest earnings call
of Intercept Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Intercept Pharmaceuticals Inc.

Provide P/S
for Intercept Pharmaceuticals Inc.

Provide P/E
for Intercept Pharmaceuticals Inc.

Provide P/OCF
for Intercept Pharmaceuticals Inc.

Provide P/FCFE
for Intercept Pharmaceuticals Inc.

Provide P/B
for Intercept Pharmaceuticals Inc.

Provide EV/S
for Intercept Pharmaceuticals Inc.

Provide EV/GP
for Intercept Pharmaceuticals Inc.

Provide EV/EBITDA
for Intercept Pharmaceuticals Inc.

Provide EV/EBIT
for Intercept Pharmaceuticals Inc.

Provide EV/OCF
for Intercept Pharmaceuticals Inc.

Provide EV/FCFF
for Intercept Pharmaceuticals Inc.

Provide EV/IC
for Intercept Pharmaceuticals Inc.

Show me price targets
for Intercept Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Intercept Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Intercept Pharmaceuticals Inc?

What are the Net Income projections
for Intercept Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Intercept Pharmaceuticals Inc?

What are the EPS projections
for Intercept Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Intercept Pharmaceuticals Inc?

What are the EBIT projections
for Intercept Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Intercept Pharmaceuticals Inc?

Compare the revenue forecasts
for Intercept Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Intercept Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Intercept Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Intercept Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Intercept Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Intercept Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Intercept Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Intercept Pharmaceuticals Inc.

Provide ROE
for Intercept Pharmaceuticals Inc.

Provide ROA
for Intercept Pharmaceuticals Inc.

Provide ROIC
for Intercept Pharmaceuticals Inc.

Provide ROCE
for Intercept Pharmaceuticals Inc.

Provide Gross Margin
for Intercept Pharmaceuticals Inc.

Provide Operating Margin
for Intercept Pharmaceuticals Inc.

Provide Net Margin
for Intercept Pharmaceuticals Inc.

Provide FCF Margin
for Intercept Pharmaceuticals Inc.

Show all solvency ratios
for Intercept Pharmaceuticals Inc.

Provide D/E Ratio
for Intercept Pharmaceuticals Inc.

Provide D/A Ratio
for Intercept Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Intercept Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Intercept Pharmaceuticals Inc.

Provide Quick Ratio
for Intercept Pharmaceuticals Inc.

Provide Current Ratio
for Intercept Pharmaceuticals Inc.

Provide Cash Ratio
for Intercept Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Intercept Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Intercept Pharmaceuticals Inc?

What is the current Free Cash Flow
of Intercept Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Intercept Pharmaceuticals Inc.

Section:

Wall Street
Price Targets

I4P Price Targets Summary
Intercept Pharmaceuticals Inc

Wall Street analysts forecast I4P stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for I4P is 31.63 EUR .

Lowest

Price Target

Not Available

Average

Price Target

31.63 EUR

81% Upside

Highest

Price Target

Not Available

Intercept Pharmaceuticals Inc Competitors:
Price Targets

AURA

Aura Biosciences Inc

114% Upside

SOBI

Swedish Orphan Biovitrum AB (publ)

8% Upside

300676

BGI Genomics Co Ltd

190% Upside

ERAS

Erasca Inc

59% Upside

AURA

Aura Biosciences Inc

114% Upside

SOBI

Swedish Orphan Biovitrum AB (publ)

8% Upside

300676

BGI Genomics Co Ltd

190% Upside

ERAS

Erasca Inc

59% Upside

ALLO

Allogene Therapeutics Inc

224% Upside

DAWN

Day One Biopharmaceuticals Inc

186% Upside

PRQR

ProQR Therapeutics NV

138% Upside

VIR

Vir Biotechnology Inc

336% Upside

Revenue
Forecast

Revenue Estimate
Intercept Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Intercept Pharmaceuticals Inc's revenue is 90%.

90%

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Intercept Pharmaceuticals Inc

Operating Income forecast
is not available for
Intercept Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Intercept Pharmaceuticals Inc

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

What is I4P's stock price target?

Price Target
31.63 EUR

According to Wall Street analysts, the average 1-year price target for I4P is 31.63 EUR .

Intercept Pharmaceuticals Inc
F:I4P

Wall Street
Price Targets

I4P Price Targets Summary
Intercept Pharmaceuticals Inc

Revenue
Forecast

Revenue Estimate
Intercept Pharmaceuticals Inc

Operating Income
Forecast

Operating Income Estimate
Intercept Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Intercept Pharmaceuticals Inc

See Also

What is I4P's stock price target?

Price Target
31.63 EUR

Company

Help

Tools

Stocks

Intercept Pharmaceuticals Inc F:I4P

Wall Street Price Targets

I4P Price Targets Summary Intercept Pharmaceuticals Inc

Revenue Forecast

Revenue Estimate Intercept Pharmaceuticals Inc

Operating Income Forecast

Operating Income Estimate Intercept Pharmaceuticals Inc

Net Income Forecast

Net Income Estimate Intercept Pharmaceuticals Inc

See Also

What is I4P's stock price target? Price Target 31.63 EUR

Company

Help

Tools

Stocks

Intercept Pharmaceuticals Inc
F:I4P

Wall Street
Price Targets

I4P Price Targets Summary
Intercept Pharmaceuticals Inc

Revenue
Forecast

Revenue Estimate
Intercept Pharmaceuticals Inc

Operating Income
Forecast

Operating Income Estimate
Intercept Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Intercept Pharmaceuticals Inc

What is I4P's stock price target?

Price Target
31.63 EUR